Skip to content
Menu

Barclays Downgrades Xylem to Equal-Weight, Lowers Price Target to $104

Benzinga Newsdesk 3 weeks ago

Analyst RatingsNewsDowngradesPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Barclays analyst William Grippin downgrades Xylem (NYSE:XYL) from Overweight to Equal-Weight and lowers the price target from $139 to $104.

Barclays analyst William Grippin downgrades Xylem (NYSE:XYL) from Overweight to Equal-Weight and lowers the price target from $139 to $104.

Read at benzinga.com

← All stock news